Current Cancer Drug Targets
Last updated ISSN 1568-0096
Current Cancer Drug Targets is published by Bentham Science Publishers in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Current Cancer Drug Targets is — and show you journals like it.
What it publishes
Recent work in Current Cancer Drug Targets concentrates on these topics, taken from its published record rather than from its own description:
- Cancer Mechanisms and Therapy
- Cancer, Hypoxia, and Metabolism
- Cancer Research and Treatments
- Cancer, Lipids, and Metabolism
- Cancer Immunotherapy and Biomarkers
- Histone Deacetylase Inhibitors Research
- Ferroptosis and cancer prognosis
- Epigenetics and DNA Methylation
- Cancer-related Molecular Pathways
- PI3K/AKT/mTOR signaling in cancer
Key facts
| Publisher | Bentham Science Publishers |
|---|---|
| ISSN | 1568-0096, 1873-5576 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 2,123 |
| Publishing since | 1956 |
| Journal website | www.benthamscience.com/ccdt/index.htm |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Current Cancer Drug Targets
Other established journals in medicine, if this one is not the right home for your paper: